fda_483 · inspection_citation · high

Wells Pharma of Houston LLC -- FDA 483: 6 observations (2025-03-28)

Event date
2025-03-28 00:00:00Z
Observed
2026-07-12 22:32:27Z
Source ID
3016710931-2025-03-28-186290
Payload hash
8778b86d3de340e364e0403e

Summary

Observation 1: Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed. Specifically, A) On March 17, 2025, you...

Informational only. Not legal, financial, or medical advice.